MedImaging Integrated Solution Inc.

6796 · TW · Healthcare / Medical Devices

44.00TWD-4.40 (-9.09%)

Price History

Full chart

Market Stats

Previous Close48.40

Open48.05

Day Range43.60 – 48.05

52-Week Range49.50 – 104.54

Volume515.79K

Market Cap2.32B

P/E (TTM)147.95

Forward P/E0.00

EPS0.39

Dividend Yield0.43%

Beta0.26

50-Day Avg56.73

200-Day Avg69.98

About

Medimaging Integrated Solution Inc. engages in the design, manufacture and sale of digital medical imaging diagnostic equipments. It also provides digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes, as well as auxiliary tools. It also offers horus scope products, including optical coherence tomography products, control units, scopes, software, and accessories; computing-based AI screening solutions in diabetic retinopathy, wound care, and medical diagnosis; endoscopy solutions comprising a micro camera module for visualization performance and patient-oriented care; and micro camera modules. The company was founded in 2010 and is headquartered in Hsinchu City, Taiwan.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Chu-Ming Cheng
Employees0
HeadquartersNo. 11, Park Avenue II, Hsinchu City, Taiwan, 300091, Taiwan
Websitehttps://www.miis.com.tw

Leadership

Mr. Chu-Ming ChengCEO, Chairman & President
Mr. Chih-Lu HsuVice President
Ms. Hui-Yu KoVice President
Ching Yi FanDeputy Director of the Finance & Accounting
Shih-Ting HuangChief Accounting Officer

Financials

Income Statement

Currency: TWD	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	367.85M	314.50M	402.47M	485.87M	502.09M	537.15M	538.92M	661.39M
Growth (%)	-	-14.50%	+27.97%	+20.72%	+3.34%	+6.98%	+0.33%	+22.72%
Cost of Revenue	150.45M	139.71M	183.19M	230.15M	247.70M	229.39M	304.60M	384.84M
Gross Profit	217.40M	174.80M	219.28M	255.72M	254.39M	307.76M	234.32M	276.55M
Gross Margin	59.10%	55.58%	54.48%	52.63%	50.67%	57.30%	43.48%	41.81%
Operating Expense	149.39M	169.10M	154.44M	169.12M	194.70M	215.84M	236.74M	258.63M
Operating Income	68.02M	5.70M	64.84M	86.60M	59.69M	91.92M	-2.42M	17.92M
Operating Margin	18.49%	1.81%	16.11%	17.82%	11.89%	17.11%	-0.45%	2.71%
EBITDA	90.48M	32.90M	90.39M	114.93M	118.98M	119.38M	42.47M	74.50M
EBITDA Margin	24.60%	10.46%	22.46%	23.65%	23.70%	22.22%	7.88%	11.26%
Net Income	58.60M	4.78M	54.12M	66.48M	70.02M	74.05M	5.61M	7.72M
Net Income Margin	15.93%	1.52%	13.45%	13.68%	13.95%	13.79%	1.04%	1.17%
R&D	76.69M	104.42M	100.74M	107.59M	126.13M	126.83M	140.68M	142.81M
R&D as % of Total Revenue	20.85%	33.20%	25.03%	22.14%	25.12%	23.61%	26.10%	21.59%
Interest Expense	138.00K	1.36M	1.28M	1.03M	1.42M	3.85M	8.61M	11.39M
Interest Expense % of Total Revenue	0.04%	0.43%	0.32%	0.21%	0.28%	0.72%	1.60%	1.72%

Balance Sheet

Currency: TWD	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	-	502.30M	618.33M	715.84M	841.41M	1.34B	1.36B	1.57B
Total Liabilities	-	164.27M	228.02M	229.72M	193.26M	548.13M	613.67M	826.34M
Total Equity	-	338.02M	390.31M	486.12M	648.15M	792.50M	742.47M	745.37M
Cash	-	132.90M	174.46M	224.26M	275.11M	474.33M	375.16M	539.00M
Total Debt	-	78.63M	135.94M	135.50M	87.67M	405.08M	443.15M	674.22M
Net Debt	-	-54.27M	-38.52M	-88.75M	-187.44M	-69.25M	67.99M	135.22M

Cash Flow

Currency: TWD	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-13.33M	55.81M	45.95M	112.79M	168.42M	-50.40M	-16.16M
Investing Cash Flow	-43.44M	-47.80M	-19.82M	-102.63M	-328.68M	7.73M	-39.65M
Financing Cash Flow	-13.46M	33.58M	23.69M	40.36M	359.80M	-57.06M	219.85M
Capital Expenditure	33.59M	41.50M	30.82M	50.74M	199.34M	125.50M	37.10M
Free Cash Flow	-46.92M	14.31M	15.13M	62.05M	-30.91M	-175.90M	-53.26M
Dividends Paid	46.94M	4.49M	36.02M	53.19M	59.81M	62.25M	17.38M
FCF to OCF	352.03%	25.64%	32.92%	55.01%	-18.36%	349.01%	329.63%
Dividend Paid to FCF	-100.04%	31.38%	238.10%	85.72%	-193.47%	-35.39%	-32.63%

Earnings

Report Date	May 13, 2022	Aug 11, 2022	Nov 10, 2022	Mar 28, 2023	May 31, 2023
EPS Estimate	0.45	0.58	0.58	-	-
EPS Actual	0.43	0.47	0.62	0.48	0.39
Surprise	-4.44%	-18.97%	6.90%	-	-
Timing	Pre-market	Pre-market	Pre-market	-	-

Key Statistics & Ratios

Market Cap2.32B

Enterprise Value2.10B

Trailing P/E147.95

Forward P/E0.00

Price / Sales3.40

Price / Book2.40

EPS0.39

Book Value21.18

Revenue (TTM)682.01M

Gross Profit (TTM)267.28M

EBITDA42.10M

Profit Margin2.10%

Operating Margin-5.88%

Return on Equity1.85%

Return on Assets-0.31%

Shares Outstanding40.23M

Shares Float22.04M

Beta0.26

Dividend Yield0.43%

Dividend Rate0.25

Payout Ratio126.35%

Dividends

20261×

0.25Jul 24, 2026

20251×

0.49Aug 19, 2025

20241×

1.61Jul 19, 2024

20231×

1.60Jul 10, 2023

20221×

1.43Jul 7, 2022

20211×

1.40Jul 29, 2021

Stock Splits

Aug 19, 20251100:1000
Jul 29, 20211276000:1000000